Financial statements Biglo Diagnostyka Laboratoryjna W Likwidacji
Balance sheet data of BIGLO DIAGNOSTYKA LABORATORYJNA W LIKWIDACJI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 814 100,29 | 741 520,74 | 806 578,06 | 726 792,88 | 647 767,76 | 420 308,73 |
| A. Fixed assets | 134 813,24 | 105 362,16 | 96 091,08 | 90 000,00 | 90 000,00 | 90 000,00 |
| B. Current assets | 679 287,05 | 636 158,58 | 710 486,98 | 636 792,88 | 557 767,76 | 330 308,73 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | - | - | - | 0,00 |
| Total liabilities | 814 100,29 | 741 520,74 | 806 578,06 | 726 792,88 | 647 767,76 | 420 308,73 |
| A. Equity | 289 372,74 | 322 370,49 | 263 190,73 | 311 993,75 | 284 171,16 | 154 166,36 |
| B. Liabilities and provisions for liabilities | 524 727,55 | 419 150,25 | 543 387,33 | 414 799,13 | 363 596,60 | 266 142,37 |
| I. Long-term liabilities | 0,00 | 0,00 | - | - | - | - |
| II. Short-term liabilities | 524 727,55 | 419 150,25 | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.